Pfizer Loses $12.93 Billion as Covid Vaccination Stalls

Pfizer

By Alexander Fabino

Newsweek

Waning concern about COVID-19 among Americans is helping to eroding billions in market value from pharmaceutical giant Pfizer Inc., a recent survey shows.

Pfizer investors triggered a stock sell-off Wednesday, pushing shares down 7.98 percent and wiping away roughly $12.93 billion in value after the company warned it may make less money next year because of static vaccination rates and a continued slowdown in demand for its COVID-19 vaccine and related products.

The drugmaker revised its 2024 revenue forecast to range between $58.5 billion and $61.5 billion, trailing the $62.66 billion analysts projected.

That reduction in revenue forecast is backed by a Kaiser Family Foundation (KFF) survey in November that found public interest in COVID-19 vaccinations is diminishing. Roughly half of U.S. adults indicated they do not plan to receive the latest vaccine (produced by Pfizer-BioNTech and Moderna), which was made available in September. That hesitancy extends to previously vaccinated individuals, with about 17.2 percent (44 million) of Americans age 18 and over having received the updated vaccine.

The Pfizer company logo is displayed on the floor of the New York Stock Exchange. Pfizer stock has fallen 7.98 percent as of Wednesday mid-afternoon, erasing billions in value, after the company warned of lower revenues in 2024. Michael M. Santiago/Getty Images

Pfizer CEO Albert Bourla told investors during an earnings call on Wednesday that its conservative outlook aims to set a reliable baseline and avoid the uncertainty that marked the previous year when Pfizer’s estimates overshot actual demand.

According to Pfizer, revenue from COVID-related products is projected to contribute about $8 billion next year, a decrease from this year’s expected $12.5 billion.

Newsweek has reached out to Pfizer via email for comment.

The KFF survey found that only about one in five adults has embraced the updated vaccine, with about 17 percent saying they will “probably not” get the new vaccine. According to the KFF, the figure marks a decline in vaccine use and suggests a diminishing reliance on COVID-19 vaccines as a steady revenue source for the company.

[…]

Via https://www.newsweek.com/pfizer-stock-down-covid-vaccine-demand-falls-kff-survey-1852203

6 thoughts on “Pfizer Loses $12.93 Billion as Covid Vaccination Stalls

  1. Pfizer has lost $13 Billion. Wait until medical fraud is confirmed, Pfizer’s immunity from lawsuits becomes voided and ends, and they get their mass murder asses sued off in courtrooms across the Earth. Although some of us are opposed to stock market betting on particular companies’ losses, people transacting Pfizer shorts, betting Pfizer stocks will drop like a rock soon, will make people a ton of money as the corporation is driven to bankruptcy…

    Liked by 2 people

  2. Pingback: Canada Reports 300% Increase in ‘Unspecified Causes’ of Death, Sparking Calls for Investigation – The Free

  3. Pingback: Pfizer Warns Vaxxed Men Not to Have Sex with Women of Childbearing Age | Worldtruth

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.